V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016035 | 270008389 | 1.44 | 72.3 | Curative (C) | 2015-07-10 | 2015-09-13 | COPP + Dacarbazine | N | N | 270012656 | COPP + DACARBAZINE |
| 270016036 | 270008391 | 0 | 19.8 | Curative (C) | 2017-11-23 | 2017-11-23 | COPP + Dacarbazine | N | N | 270012660 | COPP + DACARBAZINE |
| 270016037 | 270008397 | null | 51 | Curative (C) | 2016-11-12 | 2016-11-15 | Escalated BEACOPP | N | N | 270012666 | BEACOPP |
| 270016038 | 270016651 | 1.68 | 58.4 | Curative (C) | 2016-06-21 | 2016-07-26 | Escalated BEACOPP | N | N | 270012672 | BEACOPP |
| 270016039 | 270008401 | 1.04 | null | Curative (C) | 2016-12-15 | 2017-02-24 | COPP + Dacarbazine | N | N | 270012679 | COPP + DACARBAZINE |
| 270016040 | 270013978 | 1.59 | 60 | Curative (C) | 2015-08-19 | 2015-08-20 | Escalated BEACOPP | 02 | N | 270012681 | BEACOPP |
| 270016041 | 270019094 | 1.75 | 102 | Curative (C) | 2017-11-23 | 2017-11-29 | Cetuximab 7 day (Cycle 1) | 2 | N | 270012686 | CETUXIMAB |
| 270016042 | 270020138 | 0 | 46.6 | Adjuvant (A) | 2017-06-08 | 2017-08-19 | Trial Unspecified | 02 | N | 270012688 | TRIAL |
| 270016044 | 270008405 | 1.71 | 67.2 | Curative (C) | 2014-10-14 | 2014-11-11 | Escalated BEACOPP | null | null | 270012711 | BEACOPP |
| 270016045 | 270008407 | 1.7 | 77.5 | Curative (C) | 2017-02-04 | 2017-02-04 | Escalated BEACOPP | N | Y | 270012713 | BEACOPP |
| 270016046 | 270008409 | 1.77 | 58.4 | Curative (C) | 2014-06-14 | 2014-06-14 | COPP + Dacarbazine | N | N | 270012714 | COPP + DACARBAZINE |
| 270016047 | 270008412 | 0 | 99.4 | Curative (C) | 2018-04-02 | 2018-05-30 | CETUXIMAB | N | null | 270012719 | CETUXIMAB |
| 270016048 | 270013983 | 1.6 | null | Curative (C) | null | 2016-06-17 | CETUXIMAB | null | N | 270012720 | CETUXIMAB |
| 270016049 | 270008419 | 1.75 | 74 | Curative (C) | 2016-01-19 | 2016-03-26 | COPP + Dacarbazine | 2 | null | 270012723 | COPP + DACARBAZINE |
| 270016050 | 270008423 | 0 | 36.2 | Curative (C) | 2016-11-24 | 2017-01-26 | COPP + Dacarbazine | N | N | 270012726 | COPP + DACARBAZINE |
| 270016051 | 270008427 | 1.73 | 58.3 | Curative (C) | 2013-08-20 | 2013-10-27 | HD EuroNet-PHL-C1 COPDAC | Y | null | 270012737 | TRIAL |
| 270016052 | 270008429 | null | 59.4 | Curative (C) | 2012-08-07 | 2015-12-10 | CETUXIMAB | N | N | 270012737 | CETUXIMAB |
| 270016053 | 270008434 | 1.69 | 67.5 | Curative (C) | 2012-03-01 | 2014-03-15 | Cetuximab 7 day (>Cycle 2) | N | N | 270012753 | CETUXIMAB |
| 270016054 | 270013989 | 0 | 85.6 | null | 2013-12-04 | 2013-12-05 | COPP + Dacarbazine | N | null | 270012753 | COPP + DACARBAZINE |
| 270016055 | 270008440 | 1.86 | 86 | Curative (C) | 2015-08-07 | 2015-10-09 | Trial Unspecified | N | N | 270012757 | TRIAL |
| 270016056 | 270008442 | 0 | 88.7 | Adjuvant (A) | 2015-03-24 | 2015-05-30 | COPP + Dacarbazine | N | Y | 270012758 | COPP + DACARBAZINE |
| 270016057 | 270008442 | 0 | 80.5 | Curative (C) | 2015-12-10 | 2016-01-04 | Trial Unspecified | 01 | N | 270012758 | TRIAL |
| 270016058 | 270008447 | 1.66 | null | Curative (C) | 2014-05-27 | 2014-06-03 | BEACOPP | null | N | 270012786 | BEACOPP |
| 270016059 | 270008449 | 1.63 | 30.6 | Curative (C) | 2014-08-17 | 2014-09-06 | Cetuximab 14 day | N | N | 270012794 | CETUXIMAB |
| 270016060 | 270013994 | 1.28 | 48 | Curative (C) | 2013-09-01 | 2013-09-01 | COPP + Dacarbazine | N | N | 270012798 | COPP + DACARBAZINE |
| 270016061 | 270008452 | 0 | 66.2 | Palliative (P) | 2017-03-15 | 2017-03-18 | HD EuroNet-PHL-C1 COPDAC | 02 | N | 270012807 | TRIAL |
| 270016062 | 270016664 | 1.6 | 113.3 | null | 2016-01-31 | 2016-02-02 | Escalated BEACOPP | N | N | 270012815 | BEACOPP |
| 270016063 | 270016665 | 1.69 | 59.9 | Palliative (P) | 2016-07-07 | 2016-07-07 | Trial Unspecified | 01 | N | 270012817 | TRIAL |
| 270016064 | 270008455 | 1.56 | 28.9 | Curative (C) | 2016-05-08 | 2016-07-19 | COPP + Dacarbazine | N | N | 270012818 | COPP + DACARBAZINE |
| 270016065 | 270008456 | 1.83 | 87 | Palliative (P) | 2016-08-09 | 2016-11-26 | CETUXIMAB | 02 | N | 270012820 | CETUXIMAB |
| 270016066 | 270008459 | 1.68 | 83.6 | Curative (C) | 2014-03-02 | 2014-03-07 | Escalated BEACOPP | 2 | N | 270012822 | BEACOPP |
| 270016067 | 270008463 | null | 70.1 | Curative (C) | 2014-12-25 | 2014-12-25 | COPP + Dacarbazine | 02 | N | 270012830 | COPP + DACARBAZINE |
| 270016068 | 270008463 | 1.8 | 29.2 | Curative (C) | 2015-06-11 | 2016-01-14 | Cetuximab 7 day (Cycle 1) | N | N | 270012830 | CETUXIMAB |
| 270016069 | 270008465 | 1.69 | 42.9 | Curative (C) | 2015-11-10 | 2015-11-14 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012832 | TRIAL |
| 270016070 | 270008467 | 1.9 | null | Curative (C) | 2014-02-07 | 2014-04-17 | Cetuximab 14 day | N | N | 270012834 | CETUXIMAB |
| 270016071 | 270016670 | 1.78 | 64.5 | Curative (C) | 2015-08-17 | 2015-08-23 | Trial Unspecified | 01 | N | 270012840 | TRIAL |
| 270016072 | 270008470 | 1.71 | null | Curative (C) | 2013-01-12 | 2015-05-18 | HD EuroNet-PHL-C1 COPDAC | null | null | 270012843 | TRIAL |
| 270016073 | 270016672 | 1.81 | 59.6 | Curative (C) | 2013-09-19 | 2013-10-25 | Cetuximab 7 day (Cycle 1) | N | null | 270012861 | CETUXIMAB |
| 270016074 | 270014007 | 1.83 | 29.2 | Curative (C) | 2016-11-13 | 2017-01-27 | Escalated BEACOPP | N | N | 270012875 | BEACOPP |
| 270016075 | 270008478 | 1.89 | 33.1 | Curative (C) | 2015-02-06 | 2015-02-14 | BEACOPP-14 | N | Y | 270012882 | BEACOPP |
| 270016076 | 270008481 | 1.77 | 134 | Curative (C) | 2017-01-18 | 2017-02-12 | Cetuximab 7 day (>Cycle 2) | null | N | 270012897 | CETUXIMAB |
| 270016077 | 270019596 | 1.72 | 85 | Curative (C) | 2017-08-02 | 2017-08-20 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012904 | TRIAL |
| 270016078 | 270008485 | 1.8 | 97.1 | Curative (C) | 2014-11-02 | 2014-11-08 | BEACOPP-14 | N | N | 270012908 | BEACOPP |
| 270016079 | 270008485 | 1.58 | null | Curative (C) | 2017-10-17 | 2018-06-03 | CETUXIMAB | N | null | 270012908 | CETUXIMAB |
| 270016080 | 270008487 | 1.81 | 43.8 | Curative (C) | 2016-03-20 | 2016-06-04 | CETUXIMAB | 99 | N | 270012909 | CETUXIMAB |
| 270016081 | 270008487 | 1.78 | 85 | Curative (C) | 2016-02-23 | 2016-03-14 | Trial Unspecified | N | null | 270012909 | TRIAL |
| 270016082 | 270020224 | 1.76 | 80.4 | Curative (C) | null | 2016-05-02 | Cetuximab 14 day | 2 | N | 270012920 | CETUXIMAB |
| 270016083 | 270016678 | 1.7 | 98.2 | Curative (C) | 2016-07-01 | 2017-02-12 | Trial Unspecified | 01 | null | 270012925 | TRIAL |
| 270016084 | 270008489 | 1.76 | 104.8 | Curative (C) | 2014-12-08 | 2016-03-24 | Cetuximab 7 day (>Cycle 2) | 99 | null | 270012928 | CETUXIMAB |
| 270016085 | 270008491 | 1.63 | 62 | Curative (C) | 2016-08-03 | 2016-08-07 | COPP + Dacarbazine | N | N | 270012935 | COPP + DACARBAZINE |